{"nctId":"NCT04285580","briefTitle":"A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension","startDateStruct":{"date":"2020-06-11","type":"ACTUAL"},"conditions":["Open-Angle Glaucoma","Ocular Hypertension"],"count":37,"armGroups":[{"label":"Bimatoprost SR 10 Î¼g","type":"EXPERIMENTAL","interventionNames":["Drug: Bimatoprost SR"]},{"label":"LUMIGAN 0.01%","type":"OTHER","interventionNames":["Drug: LUMIGAN"]}],"interventions":[{"name":"Bimatoprost SR","otherNames":[]},{"name":"LUMIGAN","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of either OAG or OHT study eye, requiring IOP-lowering treatment\n* Participant is currently a nonsmoker and has not smoked any nicotine-containing products within the previous 6 months\n\nExclusion Criteria:\n\n* Current or anticipated enrollment in another investigational drug or device study\n* Females who are pregnant, nursing, or planning a pregnancy during the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Time-Matched Intraocular Pressure (IOP) for Bimatoprost SR Treated Eyes","description":"IOP is a measurement of the fluid pressure inside the study eye. A negative change from baseline indicates an improvement and a positive change from baseline indicates a worsening.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.7","spread":"5.65"},{"groupId":"OG001","value":"-4.0","spread":"5.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.5","spread":"4.46"},{"groupId":"OG001","value":"-3.2","spread":"3.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.9","spread":"3.36"},{"groupId":"OG001","value":"-5.0","spread":"2.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.8","spread":"4.31"},{"groupId":"OG001","value":"-4.4","spread":"2.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.3","spread":"3.80"},{"groupId":"OG001","value":"-4.2","spread":"3.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.9","spread":"4.59"},{"groupId":"OG001","value":"-4.2","spread":"2.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.6","spread":"4.29"},{"groupId":"OG001","value":"-5.0","spread":"2.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.3","spread":"3.66"},{"groupId":"OG001","value":"-2.1","spread":"2.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.7","spread":"3.60"},{"groupId":"OG001","value":"-1.8","spread":"4.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.4","spread":"4.04"},{"groupId":"OG001","value":"-3.2","spread":"3.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.1","spread":"3.85"},{"groupId":"OG001","value":"-3.2","spread":"1.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.2","spread":"4.42"},{"groupId":"OG001","value":"-5.0","spread":"3.34"}]}]}]},{"type":"PRIMARY","title":"Number of Patients Experiencing One or More Treatment Emergent Adverse Events (TEAEs)","description":"The number of patients who experienced one or more TEAEs","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Range of Intraocular Pressure (IOP) for Bimatoprost SR-treated Eyes","description":"IOP is a measurement of the fluid pressure inside the study eye. A negative change from baseline indicates an improvement and a positive change from baseline indicates a worsening. The range of IOP is calculated as maximum value minus minimum value per participant for each corresponding period with the smaller values showing less fluctuation of IOP.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.6","spread":"2.98"},{"groupId":"OG001","value":"0.7","spread":"3.90"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":31},"commonTop":["CONJUNCTIVAL HYPERAEMIA","INTRAOCULAR PRESSURE INCREASED","CONJUNCTIVAL HAEMORRHAGE","VISUAL FIELD DEFECT","CATARACT"]}}}